The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce student applications for the 2025 NIIMBL eXperience are now open. Students can apply to one of seven unique programs hosted by NIIMBL members across the country:
Albany College of Pharmacy and Health Sciences (ACPHS) (New York)...
NIIMBL is pleased to announce it has awarded $600K to launch seven NIIMBL eXperience programs in regions throughout the United States during the summer of 2025. Each location will host a week-long program, designed to foster diversity within the biopharmaceutical industry and introduce first- and second-year college students to new career...
he National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has contributed biopharmaceutical manufacturing ontologies to The Open Applications Group (OAGi) for further development as an open-source project. Shifting NIIMBL’s ontology work to an open-source process will encourage broader involvement and adoption of common...
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has published “ Vaccine process technology—a decade of progress ” in Biotechnology and Bioengineering . The paper serves as an update to a 2012 review titled “ Vaccine process technology ” authored by NIIMBL Executive Director Barry Buckland and explores...
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce 63 students from 41 academic institutions have been selected to take part in the 2024 NIIMBL eXperience, the largest cohort since the Program’s launch in 2019. Students will participate in one of five NIIMBL eXperience programs hosted by Albany...
